cache/45e11f21ac4056d700c60074dcbc5de1d5c024d455e2bd67a6b5ff5d435e1ba1

COM:ALKEUSPHARMA

Alkeus Pharmaceuticals Inc

  • Privately Held
OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Alkeus Pharmaceuticals Inc develops Gildeuretinol (ALK-001), an investigational therapy aimed at addressing the underlying mechanism of Stargardt disease, a genetic cause of blindness.